WeVote
Log In

Bill

Bill

A 4367

Relates to cannabinoid hemp retail sales and retailers

2025 Regular Session Introduced by Charles Fall

A 4367 would regulate cannabinoid hemp retail sales and retailers, establishing licensing, product standards, labeling, and enforcement requirements.

REFERRED TO ECONOMIC DEVELOPMENT
0
WeVote Research Nonpartisan
Bill Summary · A 4367

Summary: New York A 4367 — Relates to cannabinoid hemp retail sales and retailers

Quick facts

  • Bill number: A 4367
  • Title: Relates to cannabinoid hemp retail sales and retailers
  • Status: Referred to Economic Development (as of introduction)
  • Introduced: February 4, 2025
  • Primary sponsor: Charles Fall
  • Related bills:
    • S 9165 (prior-session)
    • A 6418 (prior-session)
    • S 5284 (companion) — listed twice as companion
  • Legislative actions so far: Two identical entries on 2025-02-04 noting the referral to Economic Development

Purpose and scope (as indicated by the title)

A 4367 is described as relating to “cannabinoid hemp retail sales and retailers.” While the text of the bill is not provided here, the title suggests the bill would address rules governing the sale of cannabinoid hemp products and the operation of retailers that sell such products. This typically encompasses regulatory definitions, licensing or registration of retailers, product standards, labeling, and enforcement mechanisms. The sponsor’s intent appears to be creating or adjusting the regulatory framework for cannabinoid hemp commerce within the state.

What is known about the provisions (availability of text is not included)

  • The specific statutory changes, definitions, requirements, exemptions, and enforcement provisions are not included in the information provided.
  • In similar bills, common areas of regulation include:
    • Retail licenses or permits for cannabinoid hemp products
    • Age restrictions for purchasers
    • Product definitions, permissible cannabinoid levels, and prohibition of certain formulations
    • Labeling, testing, and quality assurance requirements
    • Retail storefront operations and advertising rules
    • Registration or reporting requirements for retailers
    • Penalties for noncompliance and mechanisms for enforcement
  • Because the actual text is not provided, precise provisions, thresholds, timelines, and penalties cannot be stated here.

Potential impact and who would be affected

  • Retailers and businesses: Stores selling cannabinoid hemp products would be directly affected by licensing requirements, product standards, and compliance obligations. This could influence startup costs, ongoing compliance burdens, and competitive dynamics among retailers.
  • Consumers: Regulatory clarity may affect product safety, labeling, and age-verification processes, potentially improving consumer protection and confidence in cannabinoid hemp products.
  • Regulators and state agencies: The bill would create or modify regulatory responsibilities for overseeing cannabinoid hemp retail activities, including inspection, enforcement, and reporting.
  • Local governments: Depending on the bill’s structure, municipalities may implement or align local ordinances with state rules, affecting where and how stores may operate.
  • Related industries: Businesses involved in supply, testing, packaging, and distribution of cannabinoid hemp products could see changes in licensing, reporting, or compliance requirements.

Procedural and timeline considerations

  • Current status indicates the bill has been referred to the Economic Development committee, as of its intro date (February 4, 2025).
  • No further actions (hearings, amendments, votes) are listed in the provided information.
  • If advanced, standard steps would include committee hearings, passage by the chamber, possible amendments, and then consideration by the other chamber (Senate) along with potential conference committee reconciliation if needed.
  • Given the existence of companion and prior-session bills (S 5284, S 9165, A 6418), there may be ongoing negotiations or alignment with broader cannabinoid hemp policy across houses.

Notes for readers

  • The summary above reflects the information provided. For a precise understanding of A 4367’s provisions, the official bill text and fiscal notes from the sponsoring committee would be required once available.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.